Improving the Tolerogenic Potential of a ‘Vaccine’ for Type 1 Diabetes by Topical Betamethasone Therapy

Meeting for Clinicians in Training

MRS/AMS/RCP London
Wednesday 29th February 2012 
Venue: Royal College of Physicians, London

The Young Diabetologists Forum Meeting in Wales 2011

The First Meeting of Young Diabetologists Forum in Wales 2011

Miskin Manor Hotel
Friday 25th - Saturday 26th Nov 2011
Venue: Miskin - Cardiff

Progress on the Immunobiology of Intradermal Antigen Administration

 
NAIMIT Annual Meeting 

11.30 am, Tuesday 8th Nov 2011
Venue: Kasteel Oud-Poelgeest, Leiden, The Netherlands

Optimising the tolerogenic potential of a ‘vaccine’ for type 1 diabetes by topical betamethasone therapy

47th Annual Meeting of the European Association for the Study of Diabetes

3.15 pm Thursday 15th September 2011
Session: OP33 : Immunology
Speaker: Dr Mohammad Alhadj Ali
Venue: Lusitano Hall, Feira Internacional de Lisboa, Lisbon, Portugal

Improving the tolerogenic Potential of a ‘Vaccine’ for Type 1 Diabetes by Topical Betamethasone Therapy

***************** ADDDG ***************************

29th Annual Meeting of the Anglo Danish Dutch Diabetes Group

9.00-9.20 am Thursday 12th May 2011
Session 7: Immunology
Speaker: Dr Mohammad Alhadj Ali
Venue: Crieff Hydro Hotel, Perthshire, Scotland

Effects of Topical Betamethasone and Calcipotriol Therapy in Improving the Tolerogenic Potential of a ‘Vaccine’ for Type 1 Diabetes

Society for Endocrinology BES 2011 Conference

Poster Presentation: P 310
1.00 - 2.00 pm Tuesday 12th April 2011
Mohammad Alhadj Ali
Venue: International Convention Centre, Birmingham

Effects of Topical Steroid and Vitamin D Therapy in Optimizing the Tolerogenic Potential of a ‘Vaccine’ for Type 1 Diabetes

Diabetes UK Annual Professional Conference 2011

Poster Presentation: P155
11.00 am Wednesday 30th March untill 12.55 on Friday 1st April 2011
Mohammad Alhadj Ali
Venue: ICC London ExCeL